Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  bosutinib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-8 of 8 for your search:
Start Over
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3160A4-3000, B1871008, 2007-003780-50, NCT00574873
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3160A4-200, B1871006, 3160A4-200-WW, 2005-004230-40, B1871006, NCT00261846
Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 20 to 74
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3160A4-2203, B1871007, NCT00811070
Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3160A2-201, B1871014, NCT00319254
Bosutinib in Adult Patients With Recurrent Glioblastoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-190, NCT01331291
Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3160A1-100, B1871012, NCT00195260
Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3160A4-1111, NCT00759837
Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects
Phase: Phase I
Type: Biomarker/Laboratory analysis
Status: Completed
Age: 21 to 55
Sponsor: Pharmaceutical / Industry
Protocol IDs: B1871035, NCT01374139
Start Over